DESVENLAFAXINE

Advagen Pharma Ltd🇺🇸 United States

FDA Page

Effective Date: Aug 21, 2026
Approval ID: ff837eb1-24c3-4c63-9b4b-c6b5935a9b47
Products: 3 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DESVENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DESVENLAFAXINE EXTENDED-RELEASE TABLETS. DESVENLAFAXINE Extended-Release Tablets, for oral use Initial U.S. Approval: 2008

Quick Stats

Total Products3

Labelers2

Label Sections27

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.